OTC - ACTIVE INGREDIENT SECTION
Acid Phos 12X, Lycopodium 4X, Nat Sulph 7X, Opuntia Vulg 4X, Syzygium Jambol 8X, Taraxacum 8X, Uva Ursi 8X
BMNP BM10 LIQUID
- Manufacturer
- Total Operations Management LLC DBA:Bestmade Natural Products Micro | BM Private Limited
- Effective date
- 2026-06-12
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-06-17 05:10:04
Label at a glance#
ProductBM BM10 DROPS
Active ingredientTARAXACUM OFFICINALE, LYCOPODIUM CLAVATUM SPORE, SODIUM SULFATE, ARCTOSTAPHYLOS UVA-URSI LEAF, SYZYGIUM CUMINI SEED, PHOSPHORIC ACID, OPUNTIA FICUS-INDICA WHOLE
Label structure9 sections
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Uses*
Helps temporarily relieve: fatigue, weakness, frequent urination, increased thirst, and urinary discomfort.
OTC - PURPOSE SECTION
Acid Phos 12X (HPUS)......fatigue, weakness, low energy
Lycopodium 4X (HPUS)......blood sugar imbalance, digestive support
Nat Sulph 7X (HPUS)......toxicity, sluggish metabolism
Opuntia vulg 4X (HPUS)......glucose irregularities, metabolic support
Syzygium jambol 8X (HPUS)......blood sugar imbalance, pancreatic support
Taraxacum 8X (HPUS)......detox support, liver support
Uva Ursi 8X (HPUS)......urinary discomfort, kidney support
"HPUS" is the Homeopathic Pharmacopoeia of the United States.
DOSAGE & ADMINISTRATION SECTION
Use as directed.
Mix with half a cup of water and drink immediately. Repeat this process 3-4 times daily. Ages 12 and older: 10 drops. Ages 3 to 11: 5 drops. Ages under 3: consult your doctor.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If pregnant or breastfeeding, ask a health professional before use.
Stop use and ask a doctor if symptoms persist or worsen.
If you have severe symptoms, consult a doctor before use.
WARNINGS SECTION
Keep out of reach of children.
If pregnant or breastfeeding, ask a health professional before use.
Stop use and ask a doctor if symptoms persist or worsen.
If you have severe symptoms, consult a doctor before use.
INACTIVE INGREDIENT SECTION
Alcohol
HEALTH CLAIM SECTION
*Claims based on Traditional Homeopathic Practice, Not Accepted Medical Evidence, Not FDA Evaluated.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- BM BM10 DROPS
- Acid Phos, Lycopodium, Nat Sulph, Opuntia vulg, Syzygium jambol, Taraxacum, Uva Ursi
- TARAXACUM OFFICINALE
- LYCOPODIUM CLAVATUM SPORE
- SODIUM SULFATE
- SODIUM CATION
- ARCTOSTAPHYLOS UVA-URSI LEAF
- SYZYGIUM CUMINI SEED
- PHOSPHORIC ACID
- ALCOHOL
- OPUNTIA FICUS-INDICA WHOLE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 82969-2310 | 82969-2310-1 |
| 85816-2010 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TARAXACUM OFFICINALE | 39981FM375 | ACTIB |
| LYCOPODIUM CLAVATUM SPORE | C88X29Y479 | ACTIB |
| SODIUM SULFATE | 0YPR65R21J | ACTIB |
| ARCTOSTAPHYLOS UVA-URSI LEAF | 3M5V3D1X36 | ACTIB |
| SYZYGIUM CUMINI SEED | 820LSF646I | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| OPUNTIA FICUS-INDICA WHOLE | 23Z87HTQ6P | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BM BM10 DROPS | ACID PHOS, LYCOPODIUM, NAT SULPH, OPUNTIA VULG, SYZYGIUM JAMBOL, TARAXACUM, UVA URSI | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 540fdc6a-eda2-0daf-e063-6294a90a9452 | 2026-06-12 | Warnings | 82969-2310-1 82969-2310 82969231001 540fe007-bbd2-f844-e063-6394a90a3afa 540fdc6a-eda2-0daf-e063-6294a90a9452 |
| BM BM10 DROPS | ACID PHOS, LYCOPODIUM, NAT SULPH, OPUNTIA VULG, SYZYGIUM JAMBOL, TARAXACUM, UVA URSI | BM Private Limited | 53e79f25-2f58-85a2-e063-6294a90a6fa6 | 2026-06-10 | Warnings | 85816-2010 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.